Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders
Price: $1.50 Volume: 69,246
Change: $0.00 % Change: 0.00%
Day High/Low: 1.55/1.48 52 Week High/Low: 2.76/1.12
Last Traded: January 27, 2015 10:46 Transaction Volume: 700
Open: 1.50 Previous Close: 1.50
Bid: 1.50 Ask: 1.53
Bid Size: 300 Ask Size: 3600
Market Cap: 153.8m Shares Out: 102.6m
PE Ratio: N/A Dividend Yield: N/A

Opinion

Canadian Biotech comes back to life: A buyer's guide

Everything you could ever want to know about biotech, biomed and bio investments up north.

Tony Pullen   January 21, 2014
0 stars

Insider Deals: Gold Canyon (V.GCU), Metro (T.MRU) and Yellow Media (T.Y) insiders buy up

Chris Parry   November 27, 2013
0 stars

Mystery Movers: Biomed shares surging, triple digit rises all over, executives baffled

When you're standing on a launchpad and a rocket is taking off, the best place to be is on the rocket.

Chris Parry   November 19, 2013
0 stars

Latest Bullboard Posts

  • Interesting View

    1 star

    from John Maudlin, publisher of one of the world's largest investment publications. Second half of the clip. He's putting a lot of his...

    3 stars


  • Strange 100 shares trading today

    0 stars

    Counted a dozen or more 100 shares transactions, mostly by Anonymous. No idea what this all about. Have a pleasant weekend.

    1.5 stars


  • Corporate Presentation

    0 stars

    Check out their website and view the corporate presentation. It sets out the milestones for the company. Great, informative reading. I...

    1.5 stars


  • NR

    0 stars

    The next NR will likely be about the Feasibility Prototype scheduled for completion in Q1.  Hopefully they will meet this milestone and...

    4 stars


  • RE:Question for the Board

    0 stars

    Agree, not many P.R. Unless a major development or FDA approval, contracts etc., TMD has stayed away from interim promotion. Like their...

    1.5 stars